Inducing human induced pluripotent stem cell differentiation through embryoid bodies: A practical and stable approach
- PMID: 32110273
- PMCID: PMC7031760
- DOI: 10.4252/wjsc.v12.i1.25
Inducing human induced pluripotent stem cell differentiation through embryoid bodies: A practical and stable approach
Abstract
Human induced pluripotent stem cells (hiPSCs) are invaluable resources for producing high-quality differentiated cells in unlimited quantities for both basic research and clinical use. They are particularly useful for studying human disease mechanisms in vitro by making it possible to circumvent the ethical issues of human embryonic stem cell research. However, significant limitations exist when using conventional flat culturing methods especially concerning cell expansion, differentiation efficiency, stability maintenance and multicellular 3D structure establishment, differentiation prediction. Embryoid bodies (EBs), the multicellular aggregates spontaneously generated from iPSCs in the suspension system, might help to address these issues. Due to the unique microenvironment and cell communication in EB structure that a 2D culture system cannot achieve, EBs have been widely applied in hiPSC-derived differentiation and show significant advantages especially in scaling up culturing, differentiation efficiency enhancement, ex vivo simulation, and organoid establishment. EBs can potentially also be used in early prediction of iPSC differentiation capability. To improve the stability and feasibility of EB-mediated differentiation and generate high quality EBs, critical factors including iPSC pluripotency maintenance, generation of uniform morphology using micro-pattern 3D culture systems, proper cellular density inoculation, and EB size control are discussed on the basis of both published data and our own laboratory experiences. Collectively, the production of a large quantity of homogeneous EBs with high quality is important for the stability and feasibility of many PSCs related studies.
Keywords: Committed differentiation; Early prediction; Embryoid body; Heterogeneity; Induced pluripotent stem cells; Quality control; Scaling-up; Suspension culture; Three-dimensional culture.
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: No potential conflict of interest.
Figures

Similar articles
-
Early prediction of the differentiation potential during the formation of human iPSC-derived embryoid bodies.Biochem Biophys Res Commun. 2019 Aug 27;516(3):673-679. doi: 10.1016/j.bbrc.2019.06.081. Epub 2019 Jun 24. Biochem Biophys Res Commun. 2019. PMID: 31248595
-
[Scalable production of embryoid bodies with the rotay cell culture system.].Sheng Li Xue Bao. 2005 Aug 25;57(4):486-92. Sheng Li Xue Bao. 2005. PMID: 16094497 Chinese.
-
Investigation of the optimal suspension culture time for the osteoblastic differentiation of human induced pluripotent stem cells using the embryoid body method.Biochem Biophys Res Commun. 2019 Aug 6;515(4):586-592. doi: 10.1016/j.bbrc.2019.05.177. Epub 2019 Jun 6. Biochem Biophys Res Commun. 2019. PMID: 31178132
-
Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation.Biotechnol Prog. 2009 Jan-Feb;25(1):43-51. doi: 10.1002/btpr.139. Biotechnol Prog. 2009. PMID: 19198003 Free PMC article. Review.
-
Engineering Strategies for the Formation of Embryoid Bodies from Human Pluripotent Stem Cells.Stem Cells Dev. 2015 Jul 15;24(14):1595-609. doi: 10.1089/scd.2014.0427. Epub 2015 Jun 2. Stem Cells Dev. 2015. PMID: 25900308 Free PMC article. Review.
Cited by
-
Novel Approaches to Studying SLC13A5 Disease.Metabolites. 2024 Jan 24;14(2):84. doi: 10.3390/metabo14020084. Metabolites. 2024. PMID: 38392976 Free PMC article. Review.
-
Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases?Cells. 2021 Aug 5;10(8):1992. doi: 10.3390/cells10081992. Cells. 2021. PMID: 34440761 Free PMC article. Review.
-
Footprint-free induced pluripotent stem cells can be successfully differentiated into mesenchymal stromal cells in the feline model.Stem Cell Res Ther. 2025 Apr 20;16(1):195. doi: 10.1186/s13287-025-04325-2. Stem Cell Res Ther. 2025. PMID: 40254569 Free PMC article.
-
Three-Dimensional Trilineage Differentiation Conditions for Human Induced Pluripotent Stem Cells.Bioengineering (Basel). 2025 May 9;12(5):503. doi: 10.3390/bioengineering12050503. Bioengineering (Basel). 2025. PMID: 40428122 Free PMC article.
-
Induced Pluripotent Stem Cells to Model Juvenile Myelomonocytic Leukemia: New Perspectives for Preclinical Research.Cells. 2021 Sep 6;10(9):2335. doi: 10.3390/cells10092335. Cells. 2021. PMID: 34571984 Free PMC article. Review.
References
-
- Zhao Y, Zhao T, Guan J, Zhang X, Fu Y, Ye J, Zhu J, Meng G, Ge J, Yang S, Cheng L, Du Y, Zhao C, Wang T, Su L, Yang W, Deng H. A XEN-like State Bridges Somatic Cells to Pluripotency during Chemical Reprogramming. Cell. 2015;163:1678–1691. - PubMed
-
- Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010;7:618–630. - PMC - PubMed
-
- Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2008;26:101–106. - PubMed
-
- Miyoshi N, Ishii H, Nagano H, Haraguchi N, Dewi DL, Kano Y, Nishikawa S, Tanemura M, Mimori K, Tanaka F, Saito T, Nishimura J, Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Doki Y, Mori M. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell. 2011;8:633–638. - PubMed
Publication types
LinkOut - more resources
Full Text Sources